Seminal Vesicle-Sparing in Radical Cystectomy Shown to Improve Outcomes
Seminal vesicle-sparing radical cystectomy improved functional results over a median of 64 months without compromising oncologic outcomes, according to investigators.
Cystectomy
Study: Routine Surveillance Crucial After Radical Cystectomy
Low adherence to post-radical cystectomy surveillance guidelines may increase patients’ mortality risk, study findings suggest.
Study: Robotic, Open Radical Cystectomy Similarly Effective
Robot-assisted and open radical cystectomy are associated with similar 90-day complication rates, health-related quality of life, and clinical outcomes, according to a recent real-world study.
Same-Day Robotic Urologic Surgery During the COVID-19 Crisis Not Riskier
A single-institution study found no significant increase in the risk for complications or readmissions between patients who underwent robotic urologic surgery before and during the COVID-19 pandemic.
Radical Cystectomy Outcomes Improving, Study Finds
A study at Memorial Sloan Kettering Cancer Center found that the 5-year probability of dying from bladder cancer following radical cystectomy dropped from 35% to 25%.
Perioperative Hypogonadism Common in Radical Cystectomy Patients
In a small study of radical cystectomy patients, perioperative hypogonadism persisted up to 90 days after surgery.
Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer
Trimodal therapy for patients with muscle-invasive bladder cancer is associated with worse cancer-specific and overall survival and higher costs compared with radical cystectomy.
Radical Cystectomy Offers Better Survival vs Trimodal Therapy
Bladder preservation for MIBC is associated with a higher mortality rate and greater costs compared with radical cystectomy.
Gender Difference in Survival Seen After Radical Cystectomy
Females have worse disease-free, cancer-specific, overall survival versus males with bladder cancer.
Neoadjuvant Chemo vs TUR Before RC Ups Survival
Study findings suggest that clinicians should use neoadjuvant chemotherapy in many more muscle-invasive bladder cancer patients.
-
Loading...
-
Loading...
Next post in AUA 2018 Coverage
